Evaluation of Fluid Responsiveness With Recruitment Maneuver After Sternotomy in Coronary Artery Bypass Surgery
NCT ID: NCT06249568
Last Updated: 2024-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
45 participants
OBSERVATIONAL
2023-06-01
2024-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraoperative Mechanical Power and Ventilation-Associated Lung Injury: Assessing Complications
NCT06375980
Comparison of Airway Management With Bronchial Blocker and Double-Lumen Tube in Single-Lung Ventilation
NCT06299735
Effect of Low-Flow Anesthesia in Single Lung Ventilation on Postoperative Respiratory Complications
NCT06838091
Anesthesia Management of Coronary Artery Bypass Surgery and Inflammatory Biomarkers
NCT06209437
The Effects of Peep and Tidal Volume on Oxidative Stress in Cardiopulmonary Bypass Surgery
NCT03601364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Then researchers will perform a lung opening maneuver (30mmHg for 30 seconds) and measure again.
researchers will measure again after the values return to normal. researchers will give patients balanced fluid at 3ml/kg and record their values.
Can researchers predict fluid response with lung opening maneuver?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients who will have coroner arter bypass surgeon
Patients undergoing coronary artery bypass surgery will be eliminated if there are exclusion criteria. Patients who do not have exclusion criteria will be included in the study if they agree to volunteer.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* 2\. Patients with an ASA score greater than 3
* 3\. EF\<40%
* 4\. Those with contraindications to anesthetic drugs
* 5\. Patients with BMI\>30
* 6\. Patients who did not want to participate in the study
* 7\. Right ventricular dysfunction
* 8\. COPD(Chronic obstructive pulmonary disease)
* 9\. Bullous lung disease
* 10\. Moderate to severe PHT
* 11\. Severe kidney or liver disease
* 12\. Patients with hemodynamic instability in the perioperative period
* 13\. Pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meltem Sakman Yılmaz
assistant doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Bilkent Şehir Hastanesi
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E2-23-3460
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.